Efficiently Predicting HIV-1 Protease Cleavage Sites by Using Deep CNN-Assisted Hybridised Approach
Abstract
Acquired Immuno Deficiency Syndrome (AIDS) is considered a vital
danger over the feasible development and on account of its pestilence
effect and nonattendance of reparable medicines. HIV-1 AIDS can be
constrained by utilising protease inhibitors. Different procedures for
predicting sites are utilised to comprehend the highlighted sites of those
proteases. Arrangement-based sites like physiochemical elements and
construction-based sites are separated from HIV-1 proteases. In this
article, a procedure for choosing those sites using a deep CNN-assisted
hybridised approach will be used for effectively predicting cleavage sites.
The proposed methodology was evaluated based on various Type-1 and
Type-2 parameters. The proposed approach gives superior results on
Type-1 and Type-2 parameters. Data746_setset provides an accuracy of
0.924, data 1625_set provides an accuracy of 0.946, Data_schilling_set
provides an accuracy of 0.9389, Data_impens_set provides an accuracy
of 0.911 and average dataset provides an accuracy of 0.921 for Type-
1 parameters. Data746_setset provides an accuracy of 0.84664, data
1625_set provides an accuracy of 0.34179, data_schilling_set provides
an accuracy of 0.69529 and data_impens_set provides an accuracy of
0.59511 for Type-2 parameters.
Saini S, Kaur G. Efficiently Predicting HIV-1
Protease Cleavage Sites by Using Deep CNN-
Assisted Hybridised Approach. J Commun Dis.
2025;57(1):91-95.
DOI: https://doi.org/10.24321/0019.5138.202511
References
World Health Organization [Internet]. HIV and AIDS;
[cited 2023 Oct 23]. Available from: https://www.who.
int/news-room/fact-sheets/detail/hiv-aids
Gokuldhev M, Singaravel G. Local pollination-based moth
search algorithm for task-scheduling heterogeneous
cloud environment. Comput J. 2022;65(2):382-95.
[Google Scholar]
Copyright (c) 2025 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.